SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Dave who wrote (4850)8/11/1998 10:45:00 PM
From: Pierre Borczuk  Read Replies (1) | Respond to of 9523
 
> I agree that many patients cannot tolerate NSAIDs because of their >associated gastropathy and nephropathy. However, any physician worth >their salt would be crazy to use a DMARD in place of an NSAID for an OA patient

What is a DMARD ( are these the disease modifying RA agents)...if so then agree absolutely...bad side effects profile, never meant to imply widespread use of these... but COX-2 yes...

Pierre